The_DT
synthesis_NN
and_CC
immunogenicity_NN
of_IN
varicella-zoster_NN
virus_NN
glycoprotein_NN
E_NN
and_CC
immediate-early_JJ
protein_NN
-LRB-_-LRB-
IE62_NN
-RRB-_-RRB-
expressed_VBD
in_IN
recombinant_JJ
herpes_NN
simplex_NN
virus-1_NN
._.

In_IN
order_NN
to_TO
evaluate_VB
the_DT
conditions_NNS
for_IN
optimal_JJ
expression_NN
and_CC
immunogenicity_NN
of_IN
varicella-zoster_JJ
virus_NN
-LRB-_-LRB-
VZV_NN
-RRB-_-RRB-
proteins_NNS
in_IN
a_DT
herpes_NN
simplex_NN
virus-1_NN
-LRB-_-LRB-
HSV-1_NN
-RRB-_-RRB-
vector_NN
,_,
we_PRP
selected_VBD
the_DT
VZV_NN
glycoprotein_NN
E_NN
-LRB-_-LRB-
gE_NN
-RRB-_-RRB-
,_,
encoded_VBN
by_IN
ORF_NN
68_CD
and_CC
the_DT
VZV_NN
product_NN
of_IN
ORF_NN
62_CD
,_,
an_DT
immediate-early_JJ
major_JJ
tegument_NN
protein_NN
-LRB-_-LRB-
IE62_NN
-RRB-_-RRB-
._.

Three_CD
HSV\/VZV_NN
recombinants_NNS
were_VBD
generated_VBN
:_:
-LRB-_-LRB-
1_LS
-RRB-_-RRB-
VZV_NN
gE_NN
protein_NN
coding_VBG
sequences_NNS
along_IN
with_IN
the_DT
promoter_NN
region_NN
were_VBD
inserted_VBN
into_IN
the_DT
thymidine_NN
kinase_NN
-LRB-_-LRB-
TK_NN
-RRB-_-RRB-
gene_NN
of_IN
HSV-1_NN
strain_NN
KOS_NN
;_:
-LRB-_-LRB-
2_LS
-RRB-_-RRB-
VZV_NN
gE_NN
expressed_VBN
from_IN
the_DT
HSV-1_NN
ICP4_NN
promoter_NN
was_VBD
inserted_VBN
into_IN
the_DT
glycoprotein_NN
C_NN
-LRB-_-LRB-
gC_NN
-RRB-_-RRB-
gene_NN
of_IN
HSV-1_NN
strain_NN
F_NN
;_:
and_CC
-LRB-_-LRB-
3_LS
-RRB-_-RRB-
VZV_NN
IE62_NN
protein_NN
coding_VBG
sequences_NNS
under_IN
the_DT
control_NN
of_IN
the_DT
HSV-1_NN
ICP4_NN
promoter_NN
were_VBD
inserted_VBN
into_IN
the_DT
gC_NN
gene_NN
of_IN
HSV-1_NN
strain_NN
F_NN
._.

Immunoblot_NN
analysis_NN
and_CC
immunoperoxidase_NN
staining_NN
of_IN
infected_JJ
cell_NN
monolayers_NNS
demonstrated_VBD
vector_NN
expression_NN
of_IN
VZV_NN
proteins_NNS
._.

Following_VBG
intracranial_JJ
inoculation_NN
in_IN
mice_NNS
,_,
both_CC
VZV_NN
gE-HSV_NN
-LRB-_-LRB-
TK_NN
-RRB-_-RRB-
and_CC
VZV_NN
IE62-HSV_NN
-LRB-_-LRB-
gC_NN
-RRB-_-RRB-
induced_VBD
an_DT
IgG_NN
response_NN
against_IN
VZV_NN
gE_NN
or_CC
VZV_NN
IE62_NN
._.

When_WRB
tested_VBN
in_IN
cytotoxicity_NN
assays_NNS
using_VBG
T-lymphocytes_NNS
from_IN
VZV_NN
immune_JJ
human_JJ
donors_NNS
,_,
the_DT
range_NN
of_IN
precursor_NN
frequencies_NNS
for_IN
T-lymphocytes_NNS
that_WDT
recognized_VBD
VZV_NN
gE_NN
or_CC
VZV_NN
IE62_NN
was_VBD
similar_JJ
whether_IN
these_DT
proteins_NNS
were_VBD
expressed_VBN
by_IN
HSV-1_NN
or_CC
a_DT
vaccinia_NN
vector_NN
._.

These_DT
experiments_NNS
demonstrate_VBP
that_IN
HSV-1_NN
is_VBZ
a_DT
competent_JJ
vector_NN
for_IN
expression_NN
of_IN
these_DT
VZV_NN
proteins_NNS
and_CC
support_VBP
the_DT
feasibility_NN
of_IN
engineering_VBG
a_DT
combined_JJ
vaccine_NN
for_IN
these_DT
closely_RB
related_JJ
alpha-herpesviruses_NNS
._.

